Janhavi Bhandari

Discovery of Potent and Selective Inhibitors of CDPK1 from <i>C. parvum</i> and <i>T. gondii</i>

Ryan C. Murphy, Kayode K. Ojo, E.T. Larson et al. · ACS Medicinal Chemistry Letters · 2010 · 138 citations · Full text

Pharmaceutical Science, Drug Target, Immunology +22

High-throughput protein production and purification at the Seattle Structural Genomics Center for Infectious Disease

Cassie M. Bryan, Janhavi Bhandari, Alberto J. Napuli et al. · Acta Crystallographica Section F Structural Biology and Crystallization Communications · 2011 · 96 citations · Full text

Structural Bioinformatics, Molecular Biology, Infectious Disease +17

Identification of inhibitors for putative malaria drug targets among novel antimalarial compounds

Gregory J. Crowther, Alberto J. Napuli, James H. Gilligan et al. · Molecular and Biochemical Parasitology · 2010 · 76 citations

Antiparasitic Agent, Medicine, Malaria +7

Povetacicept, an Enhanced Dual <scp>APRIL</scp>/<scp>BAFF</scp> Antagonist That Modulates B Lymphocytes and Pathogenic Autoantibodies for the Treatment of Lupus and Other B Cell–Related Autoimmune Diseases

Lawrence S. Evans, Katherine E. Lewis, Daniel Demonte et al. · Arthritis & Rheumatology · 2023 · 51 citations · Full text

Buffer Optimization of Thermal Melt Assays of Plasmodium Proteins for Detection of Small-Molecule Ligands

Gregory J. Crowther, Alberto J. Napuli, Andrew P. Thomas et al. · SLAS DISCOVERY · 2009 · 44 citations · Full text